Puma Biotechnology PBYI
NASDAQ PBYI
$9.51 -0.33 (-3.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Puma Biotechnology (PBYI) Cost of Revenue (2017 - 2026)

Updated

Puma Biotechnology (PBYI) posted Cost of Revenue of $12.48 million for Q2 2026, up 1.4% from $12.3 million a year earlier and up 19.7% from the prior quarter.

Analysis

Puma Biotechnology (PBYI) Cost of Revenue (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cost of Revenue at Puma Biotechnology was $58.2 million, down 11.7% year-over-year; for FY2025, it was $58.16 million, down 9.7% from FY2024.

  • Annual Cost of Revenue shows a five-year compound annual growth rate of 8.1% (FY2020 to FY2025).
  • In prior years, Puma Biotechnology's Cost of Revenue was $64.4 million in FY2024 (+2.7%), $62.68 million in FY2023 (+13.8%), $55.09 million in FY2022 (-13.5%) and $63.7 million in FY2021 (+61.8%).
  • Quarterly Cost of Revenue has run from a low of $10.28 million in Q3 2021 to a high of $29.1 million in Q3 2024 over five years.
  • On a year-over-year basis, Cost of Revenue increased in four of the last eight quarters, with growth averaging 12.3%.
  • The strongest year-over-year quarter for Cost of Revenue in the past five years was Q3 2024, with growth of 119.0%; the weakest was Q1 2022, with a decline of 63.3%.
  • According to Business Quant data, Cost of Revenue for the three prior quarters was $10.42 million (Q1 2026), $23.13 million (Q4 2025) and $12.17 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Puma Biotechnology 485.99 Mn 98.62 Mn 44.03 Mn 12.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.48 Mn
Mar 31, 2026 10.42 Mn
Dec 31, 2025 23.13 Mn
Sep 30, 2025 12.17 Mn
Jun 30, 2025 12.30 Mn
Mar 31, 2025 10.56 Mn
Dec 31, 2024 13.92 Mn
Sep 30, 2024 29.10 Mn
Jun 30, 2024 10.66 Mn
Mar 31, 2024 10.73 Mn
Dec 31, 2023 24.32 Mn
Sep 30, 2023 13.28 Mn
Jun 30, 2023 11.86 Mn
Mar 31, 2023 13.22 Mn
Dec 31, 2022 16.84 Mn
Sep 30, 2022 12.50 Mn
Jun 30, 2022 14.92 Mn
Mar 31, 2022 10.84 Mn
Dec 31, 2021 11.90 Mn
Sep 30, 2021 10.28 Mn
API Access

Puma Biotechnology Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=PBYI&period=max&api_key=YOUR_API_KEY